Pediatrix Medical Group, Inc. (MD)
NYSE · Healthcare · Medical Care Facilities
$26.10+0.50%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $2.1B
- P/E (trailing)
- 12.5
- Forward P/E
- 10.7
- 52-week range
- $15.70 – $27.94
- 52-week change
- +47.56%
- EPS (trailing)
- $2.09
- Next earnings
- Nov 2, 2026
Fiscal year to Dec 2025
- Revenue
- $1.9B (−4.92%)
- Net income
- $165M
- Operating margin
- 10.9%
- Diluted EPS
- $1.94
From the company’s annual report on SEC EDGAR.
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc.
Headquarters: Sunrise, United States · 4,280 employees · pediatrix.com